19938 Federal Register / Vol. 87, No. 66 / Wednesday, April 6, 2022 / Notices 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, 1600 Clifton Road 

NE, Mailstop US8–1, Atlanta, Georgia 

30329–4027, Telephone: (404) 718– 

8833; Email: GAnderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07246 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CE22– 

012, The CDC National Centers of 

Excellence in Youth Violence 

Prevention (YVPCs): Rigorous 

Evaluation of Prevention Strategies To 

Prevent and Reduce Community Rates 

of Youth Violence; Cancellation of 

Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services 

ACTION: Notice. 

FOR FURTHER INFORMATION CONTACT: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, CDC, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341–3717, 

Telephone: (404) 639–6473, Email: 

AWilkes@cdc.gov. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given of a change in the meeting 

of the Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel—RFA–CE22–012, The 

CDC National Centers of Excellence in 

Youth Violence Prevention (YVPCs): 

Rigorous Evaluation of Prevention 

Strategies to Prevent and Reduce 

Community Rates of Youth Violence; 

June 21–22, 2022, 8:30 a.m.–5:30 p.m., 

EDT. 

The web conference was published in 

the Federal Register on February 1, 

2022, Volume 87, Number 21, page 

5482. 

This meeting is being canceled in its 

entirety. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07243 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0046] 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Advisory Committee to the 

Director, Centers for Disease Control 

and Prevention (ACD, CDC). This 

meeting is open to the public. Time will 

be available for public comment. The 

meeting will be webcast live via the 

World Wide Web. 

DATES: The meeting will be held on May 

3, 2022, from 11:00 a.m. to 4:00 p.m., 

EDT (times subject to change). The 

public may submit written comments 

from April 6, 2022 through April 28, 

2022. 

ADDRESSES: You may submit comments 

identified by Docket No. CDC–2022– 

0046 by any of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Kerry Caudwell, MPA, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–10, Atlanta, Georgia 30329–4027. 

Attn: Docket No. CDC–2022–0046. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

Written public comments submitted 

up to 72 hours prior to the ACD meeting 

will be provided to ACD members 

before the meeting. 

Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Kerry Caudwell, MPA, Centers for 

Disease Control and Prevention, Office 

of the Chief of Staff, 1600 Clifton Road 

NE, MS H21–10, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

7000; Email Address: ACDirector@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Advisory Committee to 

the Director (ACD), CDC, shall advise 

the Secretary, HHS, and the Director, 

CDC, on policy and broad strategies that 

will enable CDC to fulfill its mission of 

protecting health through health 

promotion, prevention, and 

preparedness. The committee 

recommends ways to prioritize CDC’s 

activities, improve results, and address 

health disparities. It also provides 

guidance to help CDC work more 

effectively with its various private and 

public sector constituents to make 

health protection a practical reality. 

Matters to be Considered: The agenda 

will include discussions regarding 

CDC’s current and future work in the 

following topic areas: (1) Data 

modernization; (2) laboratory quality; 

and (3) health equity. The Advisory 

Committee to the Director (ACD) will 

consider the formation of working 

groups for each of the first two topics 

and hear a report from the existing 

health equity working group on the 

third topic. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 


lotter on DSK11XQN23PROD with NOTICES1